Med Chem Res (2016) 25:539–552
549
00 00
134.2, 133.6 (q, J = 60 Hz, C2), 133.2 (C 1), 130.6 (C 2,
2-(Trifluoromethyl)-4-(1,2-dihydro-2-oxobenzo[d]imidazol-3-
0
0
0
0
yl) benzonitrile (7a) Yield 62 %; White Solid; mp
C 6), 129.1 (C 6), 127.6 (d, J = 34 Hz, C5), 125.6 (C 3),
0
0
0
232–233 °C; IR (KBr) m max: 3189, 3149 (N–Hstretch),
3072 (C–Harom), 2957, 2895, 2820 (C–Halk), 2230 (C:N),
1720 (C=O), 1611 (N–Hbend), 1575, 1507, 1481, 1439 (C=
124.0 (C 5), 122.8, 122.5 (q, CF3), 120.6 (C 2), 118.8 (C
0
0
00
4), 115.6 (C 3, C 5), 115.8 (C3), 114.2 (CN), 102.3 (C1),
44.9 (CH2); HRMS (ESI): m/z calculated C H F N O
13 4 3 2
-
[M–H] : 438.08711; Found: 438.087.
23
Carom), 1385, 1319, 1240, 1185, 1127, 1053 (C–Hbend),
-
1
1
1
272, 558 (C–CF3) cm ; H NMR (400 MHz, CDCl ,
3
ppm): d 9.372 (s, 1H, NH), 8.14 (s, 1H, H-2), 8.03 (d, 2H,
H-5,H-6), 7.2 (m, 4H, phenyl); C NMR (100 MHz,
4-(1-Allyl-1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)-2-(tri-
fluoromethyl) benzonitrile (9b) Yield 85 %; Colorless
needles; mp 107–108 °C; IR (KBr) m max: 3070 (C–Harom),
1
3
CDCl , ppm): d 152.9 (C=O), 139.2 (C4), 135.6 (C6),
3
0
0
1
33.8, 133.1 (q, J = 65 Hz, C2), 128.5 (C 1), 127.6
0
2925, 2853 (C–H ), 2232 (C:N), 1709 (C=O), 1607,
alk
(
d, J = 34 Hz, C5), 123.3 (C 6), 122.8 (C 3), 122.5
0
1572, 1506, 1489, 1435, 1400 (C=Carom), 1347, 1308,
0
(
q, CF3), 121.6 (C), 120.4 (C 5), 114.8 (CN), 110.0 (C 2),
0
1280, 1225, 1177, 1146, 1132, 1052 (C–Hbend), 1280, 557
-1
1
1
08.7 (C 4), 106.6 (C1); HRMS (ESI): m/z calculated for
(C–CF3) cm
8.15(s, 1H, H-2), 8.01 (d, J = 1.2 Hz, 2H, H-5, H-6),
.06–7.27 (m, 4H, phenyl), 5.90–5.98 (m, 1H,CH), 5.34
(dd, J = 5.6 Hz, 2 H, = CH2), 4.59 (d, J = 5.2 Hz, 2 H,
; H NMR (400 MHz, CDCl , ppm): d
3
?
C H F N O [M?H] : 304.06922; Found: 304.069.
1
5 8 3 3
7
2-(Chloro)-4-(1,2-dihydro-2-oxobenzo[d]imidazol-3-yl) ben-
1
3
zonitrile (7b) Yield 62 %; White Solid; mp 225–226 °C;
IR (KBr) m max: 3188, 3150(N–Hstretch), 3076 (C–Harom),
–CH2–); C NMR (100 MHz, CDCl , ppm): d 152.3 (C=
3
O), 139.4 (C4), 136.0 (C6), 134.7, 134.0 (q, J = 66 Hz,
0 0 0 00
2
924, 2853 (C–Halkane), 2230 (C:N), 1719 (C=O), 1611
N–Hbend), 1575, 1510, 1481, 1438 (C=Carom), 1387, 1319,
240, 1195, 1127, 1053 (C–Hbend), 830, 701 (C–Clbend
C2), 132.1(C 1), 131.2(C 6), 129.5(C 3), 127.3(C 2),
0 0
123.5, 123.0 (q, CF3), 123.0(d, C5), 122.2(C 5), 121.3(C
(
0
00
1
)
2),120.6 (C3), 118.5 (C 4), 117.6 (C 3), 115.1(CN), 108.0
00
-
1
1
cm ; H NMR (400 MHz, CDCl , ppm): d 8.17 (s, 1H),
(C1), 43.7 (C 1); HRMS (ESI): m/z calculated for
?
C H F N O [M?H] : 344.10052; Found: 344.0986.
3
1
.01 (d, 2H), 7.39 (m, 4H); C NMR (100 MHz, CDCl3,
3
8
18
12 3 3
0
ppm): d 152.3 (C=O), 139.4 (C4), 136.4 (C2), 134.5 (C 1),
0
0
0
1
33.9 (C6), 123.3 (C 6), 122.9 (C 3), 122.2 (C 5), 119.5
0
2-Chloro-4-{3-[2-(4-fluorophenyl)-2-oxoethyl]-2-oxo-2,3-
dihydro-1H-benzimidazol-1-yl}benzonitrile (9c) Yield
0
(
C 2), 117.6 (C5), 116.2 (C 4), 115.1 (C3), 114.2 (CN),
09.1 (C), 105.2 (C1); HRMS (ESI): m/z calculated for
-
C H ClN O [M–H] : 268.02831; Found: 268.02609.
1
82 %; White Solid; mp 175–176 °C; IR (KBr) m max: 3072
(C–Harom), 2925, 2852 (C–Halk), 2229 (C:N), 1720, 1693
1
4
8
3
(2 C=O), 1602, 1510, 1484, 1437 (C=Carom), 1382, 1330,
General procedure for the synthesis of compounds (9a–c)
-(Substituted)-4-(1,2-dihydro-2-oxobenzo[d]imidazol-3-
1240, 1195, 1130, 1054 (C–Hbend), 829, 695 (C–Clbend
-
)
1 1
cm ; H NMR (400 MHz, CDCl , ppm): d 3.7 (s, 2 H,
3
2
–CH2) 7.09–7.13 (m, 4H,), d 7.13–7.16 (m, 4H, phenyl),
7.37–7.41 (m, 2H, H-5, H-6), 8.01 (s, 4H, phenyl) 8.28 (s,
yl) benzonitrile 7a or 7b (5 mmol) was added to a mixture
of compound (R–X) and Cs CO (10 mmol) in DMF
1
3
2
3
1H, H-2); C NMR (100 MHz, CDCl , ppm): d 192.05
3
00
(
25.0 ml). After 12 h, 50 ml of ice water was added
(C=O), 157.2 (C 4), 152.3 (N–C=O), 139.4 (C4), 136.4
0
00
00
00
dropwise. The resulting suspension was filtered, and the
filter cake was dried in a vacuum oven. The solid was
purified by flash chromatography (50 % ethyl acetate in
hexane) to afford the title compound (9a–c).
(C2), 134.5 (C 1), 133.9 (C6), 131.7(C 1), 130.5 (C 2, C
0
0
0
0
6), 127.3 (C 6), 123.5 (C 3), 122.7 (C 5), 119.5 (C 2),
00
0
00
118.2 (C5), 116.5 (C 4), 115.6 (C 3, C 5), 115.1 (C3),
114.0 (CN), 109.1 (C), 104.2 (C1), 44.1 (CH2); HRMS
?
ESI): m/z calculated for C H ClFN O [M?H] :
(
2
2
13
3 2
4
1
-{3-[2-(4-Fluorophenyl)-2-oxoethyl]-2-oxo-2,3-dihydro-
H-benzimidazol-1-yl}-2-(trifluoromethyl) benzonitrile
406.8089; Found: 406.9141.
(
9a) Yield 80 %; Colorless needles; mp 178–180 °C; IR
X-ray diffraction analysis
(
KBr) m max: 3063 (C–Harom), 2954, 2916, 2851 (C–
Halkane), 2236 (C:N), 1712, 1696 (2 C=O), 1602, 1508,
The single crystal of the compound was developed by slow
evaporation of chloroform and alcohol (1:1 ratio). The
1
489, 1437 (C=Caromatic), 1365, 1347, 1312, 1240, 1180,
-1 1
161, 1135, 1055 (C–Hbend), 1276, 550 (C–CF3) cm ; H
1
XRD data for
a
good-quality single crystal
3
NMR (400 MHz, CDCl , ppm): d 8.23(s, 1H, H-2), 8.03 (s,
(0.40 9 0.34 9 0.22 mm ) was collected at 296 K tem-
perature with a Bruker 3-circle diffractometer (Bruker
Nonius SMART APEX 2) equipped with CCD area
detector. Bruker SMART software was used for data col-
lection and also for indexing reflections and unit cell
3
4
H, phenyl), 7.19–7.23 (m, 2H, H-5, H-6), 7.09–7.13 (m,
3
1
4
H, phenyl), 3.72 (s, 2 H, –CH2–CO);
C NMR
0
0
(
100 MHz, CDCl , ppm): d 193.5 (C=O), 157.2 (C 4),
3
0
1
53.3 (N–C=O), 138.3 (C4), 136.5 (C 1), 135.6 (C6),
123